BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 23965521)

  • 1. Antibody-mediated rejection, T cell-mediated rejection, and the injury-repair response: new insights from the Genome Canada studies of kidney transplant biopsies.
    Halloran PF; Reeve JP; Pereira AB; Hidalgo LG; Famulski KS
    Kidney Int; 2014 Feb; 85(2):258-64. PubMed ID: 23965521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial transcripts uncover a previously unknown phenotype: C4d-negative antibody-mediated rejection.
    Sis B; Halloran PF
    Curr Opin Organ Transplant; 2010 Feb; 15(1):42-8. PubMed ID: 20009933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disappearance of T Cell-Mediated Rejection Despite Continued Antibody-Mediated Rejection in Late Kidney Transplant Recipients.
    Halloran PF; Chang J; Famulski K; Hidalgo LG; Salazar ID; Merino Lopez M; Matas A; Picton M; de Freitas D; Bromberg J; Serón D; Sellarés J; Einecke G; Reeve J
    J Am Soc Nephrol; 2015 Jul; 26(7):1711-20. PubMed ID: 25377077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcineurin Inhibitor Minimization With Ixazomib, an Investigational Proteasome Inhibitor, for the Prevention of Antibody Mediated Rejection in a Preclinical Model.
    Reese SR; Wilson NA; Huang G; Redfield RR; Zhong W; Djamali A
    Transplantation; 2015 Sep; 99(9):1785-95. PubMed ID: 25919767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in pathologic features and graft outcomes in antibody-mediated rejection of renal allografts due to persistent/recurrent versus de novo donor-specific antibodies.
    Haas M; Mirocha J; Reinsmoen NL; Vo AA; Choi J; Kahwaji JM; Peng A; Villicana R; Jordan SC
    Kidney Int; 2017 Mar; 91(3):729-737. PubMed ID: 28104301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concurrent acute cellular rejection is an independent risk factor for renal allograft failure in patients with C4d-positive antibody-mediated rejection.
    Matignon M; Muthukumar T; Seshan SV; Suthanthiran M; Hartono C
    Transplantation; 2012 Sep; 94(6):603-11. PubMed ID: 22932115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C4d-negative antibody-mediated rejection: A pathologist's perspective and clinical outcome.
    Nigam LK; Vanikar AV; Kanodia KV; Patel RD; Suthar KS; Patel HV
    Saudi J Kidney Dis Transpl; 2018; 29(1):39-49. PubMed ID: 29456206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reassessing the Significance of Intimal Arteritis in Kidney Transplant Biopsy Specimens.
    Salazar ID; Merino López M; Chang J; Halloran PF
    J Am Soc Nephrol; 2015 Dec; 26(12):3190-8. PubMed ID: 25918035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microvascular inflammation in early protocol biopsies of renal allografts in cases of chronic active antibody-mediated rejection.
    Tsuji T; Yanai M; Itami H; Ishii Y; Akimoto M; Fukuzawa N; Harada H; Fukasawa Y
    Nephrology (Carlton); 2015 Jul; 20 Suppl 2():26-30. PubMed ID: 26031582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bortezomib for refractory acute antibody-mediated rejection in kidney transplant recipients: A single-centre case series.
    De Sousa-Amorim E; Revuelta I; Diekmann F; Cofan F; Lozano M; Cid J; Palou E; Sole M; Campistol JM; Oppenheimer F
    Nephrology (Carlton); 2016 Aug; 21(8):700-4. PubMed ID: 26492594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Designation of T-cell-mediated rejection type Ib and IIa reflects the type of rejection rather than the severity in the Banff classification.
    Wu K; Budde K; Schmidt D; Neumayer HH; Rudolph B
    Exp Clin Transplant; 2014 Oct; 12(5):415-23. PubMed ID: 25299369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural killer cell infiltration is discriminative for antibody-mediated rejection and predicts outcome after kidney transplantation.
    Yazdani S; Callemeyn J; Gazut S; Lerut E; de Loor H; Wevers M; Heylen L; Saison C; Koenig A; Thaunat O; Thorrez L; Kuypers D; Sprangers B; Noël LH; Van Lommel L; Schuit F; Essig M; Gwinner W; Anglicheau D; Marquet P; Naesens M
    Kidney Int; 2019 Jan; 95(1):188-198. PubMed ID: 30396694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Banff 2013 update: Pearls and pitfalls in transplant renal pathology.
    Hara S
    Nephrology (Carlton); 2015 Jul; 20 Suppl 2():2-8. PubMed ID: 26031578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute T cell-mediated rejection accompanied by C4d-negative acute antibody-mediated rejection and cell debris in tubulus: A case report.
    Takamura T; Yamamoto I; Nakada Y; Katsumata H; Yamakawa T; Furuya M; Mafune A; Kobayashi A; Tanno Y; Miki J; Ohkido I; Tsuboi N; Yamamoto H; Yokoo T
    Nephrology (Carlton); 2015 Jul; 20 Suppl 2():70-4. PubMed ID: 26031591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Banff Component Scoring-based Histologic Assessment of Bortezomib-based Antibody-mediated Rejection Therapy.
    Sadaka B; Ejaz NS; Shields AR; Cardi MA; Wadih G; Witte D; Abu Jawdeh BG; Alloway RR; Woodle ES
    Transplantation; 2015 Aug; 99(8):1691-9. PubMed ID: 25803498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective assessment of antidonor cellular alloreactivity is a tool for guidance of immunosuppression in kidney transplantation.
    Bestard O; Cruzado JM; Lucia M; Crespo E; Casis L; Sawitzki B; Vogt K; Cantarell C; Torras J; Melilli E; Mast R; Martinez-Castelao A; Gomà M; Reinke P; Volk HD; Grinyó JM
    Kidney Int; 2013 Dec; 84(6):1226-36. PubMed ID: 23783240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The molecular phenotypes of rejection in kidney transplant biopsies.
    Halloran PF; Famulski K; Reeve J
    Curr Opin Organ Transplant; 2015 Jun; 20(3):359-67. PubMed ID: 25944235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular assessment of disease states in kidney transplant biopsy samples.
    Halloran PF; Famulski KS; Reeve J
    Nat Rev Nephrol; 2016 Sep; 12(9):534-48. PubMed ID: 27345248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression patterns of B cells in acute kidney transplant rejection.
    Carpio VN; Noronha Ide L; Martins HL; Jobim LF; Gil BC; Külzer AS; Loreto Mda S; Gonçalves LF; Manfro RC; Veronese FV
    Exp Clin Transplant; 2014 Oct; 12(5):405-14. PubMed ID: 25299368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subclinical Rejection Phenotypes at 1 Year Post-Transplant and Outcome of Kidney Allografts.
    Loupy A; Vernerey D; Tinel C; Aubert O; Duong van Huyen JP; Rabant M; Verine J; Nochy D; Empana JP; Martinez F; Glotz D; Jouven X; Legendre C; Lefaucheur C
    J Am Soc Nephrol; 2015 Jul; 26(7):1721-31. PubMed ID: 25556173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.